[Hiring] Director of Early Pipeline & Corporate Strategy @argenx BV

argenx BV; Deutschland; Remote; EUR 80.000 - 100.000; Vollzeit

Zusammenfassung

A leading biotech company is hiring a remote Director of Early Pipeline & Corporate Strategy. The role involves shaping strategic direction and aligning early R&D initiatives. Candidates should have 8–12+ years in biotech strategy and an advanced degree. This position offers competitive compensation and a flexible work environment.

Leistungen

Competitive compensation and benefits

Flexible work environment

Values-based culture focused on innovation

Qualifikationen

• 8–12+ years of experience in biotech/pharma strategy, finance, corporate development, or consulting.
• Experience with early-stage pipelines and scientific uncertainty.
• Strong modeling capabilities to distill complex inputs.

Aufgaben

• Shape the strategic direction of the Immunology Innovation Program.
• Build business cases for early opportunities across immunology indications.
• Track competitive landscape and scientific trends.

Kenntnisse

Strategic thinker

Analytical capabilities

Excellent communication

Ability to foster collaboration

Ausbildung

Advanced degree in life sciences or MBA

Jobbeschreibung

Sep 05, 2025 - argenx BV is hiring a remote Director of Early Pipeline & Corporate Strategy. Salary: competitive compensation. Location: USA, Belgium, Switzerland.

This description is a summary of our understanding of the job description. Click on 'Apply' button to find out more.

Role Description

The Director of Early Pipeline & Corporate Strategy plays a pivotal role in shaping the strategic direction of our Immunology Innovation Program (IIP) and aligning early R&D initiatives with broader corporate objectives. This position also contributes to high-level portfolio strategy, long-term forecasting, and the assessment of business development opportunities. This is a high-visibility, cross-functional role that bridges science and strategy. You’ll work closely with leadership and global stakeholders across R&D, corporate development, clinical, commercial, and finance teams.

• Build business cases for early IIP opportunities across immunology indications.
• Provide strategic input into discovery-stage efforts and target prioritization.
• Integrate IIP portfolio insights into long-range planning and development roadmaps.
• Develop frameworks to assess translational and commercial potential of early-stage assets.
• Track competitive landscape and scientific trends to inform early investment decisions.
• Support portfolio reviews and cross-functional prioritization.
• Conduct scenario planning and risk/benefit analysis to inform pipeline decisions.
• Contribute to the company’s strategic planning and long-term corporate vision.
• Lead valuation and forecasting models across therapeutic areas.
• Collaborate with commercial and HEOR teams to understand unmet need and opportunity spaces.
• Work closely with Science, Clinical Development, Regulatory, Business Development, and Finance teams.
• Contribute to strategic evaluations of external partnerships or acquisition opportunities.
• Help embed strategic frameworks for consistent, data-driven decision-making.

Qualifications

• 8–12+ years of experience in biotech/pharma strategy, strategic finance, corporate development, or consulting.
• Advanced degree in life sciences or an MBA with strong scientific fluency (Immunology background preferred).
• Experience working with early-stage pipelines and scientific uncertainty.
• Strong analytical and modeling capabilities with the ability to distill complex inputs into clear recommendations.
• Strategic thinker with excellent communication and influencing skills.
• Comfortable operating in a dynamic, cross-functional, and global environment.
• Proven ability to lead through influence and foster collaboration across diverse teams.

Benefits

• Competitive compensation and benefits
• A flexible, inclusive work environment
• A values-based culture focused on innovation, integrity, and impact